TendoNova Overview

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 12

TendoNova General Information

Description

Developer of a surgical device designed to assist minimally invasive orthopedic procedures. The company offers a micro-invasive device to perform percutaneous tenotomy under ultrasound guidance, enabling clinicians with modalities that are customizable to individual patient needs without associated costs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 75 Fifth Street, NorthWest
  • Suite 2160
  • Atlanta, GA 30308
  • United States
+1 (877)
Primary Industry
Surgical Devices
Other Industries
Therapeutic Devices
Clinics/Outpatient Services
Other Devices and Supplies
Corporate Office
  • 75 Fifth Street, NorthWest
  • Suite 2160
  • Atlanta, GA 30308
  • United States
+1 (877)

TendoNova Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TendoNova Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Accelerator/Incubator 14-Mar-2025 Completed Generating Revenue
10. Mezzanine 29-Aug-2024 Completed Generating Revenue
9. Later Stage VC 19-Mar-2024 Completed Generating Revenue
8. Later Stage VC 09-Jan-2024 Completed Generating Revenue
7. Later Stage VC 27-Dec-2022 Completed Generating Revenue
6. Later Stage VC 22-Aug-2022 Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Grant 02-Nov-2019 Completed Generating Revenue
3. Grant 15-Nov-2018 $150K Completed Generating Revenue
2. Grant 01-Aug-2017 $43.6K Completed Startup
To view TendoNova’s complete valuation and funding history, request access »

TendoNova Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series S-3
Series S-2
Series S-1 1,100,000 $0.000010 $0.5 $0.5 1x $0.5 6.62%
Series S 3,000,000 $0.000010 $0.7 $0.7 1x $0.7 0.64%
To view TendoNova’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

TendoNova Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a surgical device designed to assist minimally invasive orthopedic procedures. The company offers a micro-i
Surgical Devices
Atlanta, GA
7 As of 2022

Naples, FL
 

North Billerica, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TendoNova Competitors (4)

One of TendoNova’s 4 competitors is Arthrex, a Private Equity-Backed company based in Naples, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arthrex Private Equity-Backed Naples, FL
HydroCision Venture Capital-Backed North Billerica, MA
Pega Medical Corporate Backed or Acquired Laval, Canada
Tenex Health Formerly PE-Backed Lake Forest, CA
To view TendoNova’s complete competitors history, request access »

TendoNova Patents

TendoNova Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12144522-B2 Devices for tissue treatment and methods of use thereof Active 06-Apr-2018
US-20250302504-A1 Devices for tissue treatment and methods of use thereof Pending 06-Apr-2018
EP-3773266-A1 Improved devices for tissue treatment and methods of use thereof Pending 06-Apr-2018
EP-3773266-A4 Improved devices for tissue treatment and methods of use thereof Pending 06-Apr-2018
US-20210145477-A1 Improved devices for tissue treatment and methods of use thereof Active 06-Apr-2018 A61B17/32002
To view TendoNova’s complete patent history, request access »

TendoNova Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TendoNova Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Phoenix Bioscience Core Accelerator/Incubator
Ariel Savannah Angel Partners Angel Group Minority
InnerProduct Partners Venture Capital Minority
Millworks Fund Angel Group Minority
NFL Players Association Corporation Minority
You’re viewing 5 of 12 investors. Get the full list »

TendoNova FAQs

  • Where is TendoNova headquartered?

    TendoNova is headquartered in Atlanta, GA.

  • What is the size of TendoNova?

    TendoNova has 7 total employees.

  • What industry is TendoNova in?

    TendoNova’s primary industry is Surgical Devices.

  • Is TendoNova a private or public company?

    TendoNova is a Private company.

  • What is TendoNova’s current revenue?

    The current revenue for TendoNova is .

  • How much funding has TendoNova raised over time?

    TendoNova has raised $4.17M.

  • Who are TendoNova’s investors?

    Phoenix Bioscience Core, Ariel Savannah Angel Partners, InnerProduct Partners, Millworks Fund, and NFL Players Association are 5 of 12 investors who have invested in TendoNova.

  • Who are TendoNova’s competitors?

    Arthrex, HydroCision, Pega Medical, and Tenex Health are competitors of TendoNova.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process